CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 99  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0782
LYS 10.0228
GLU 20.0128
LEU 30.0083
ARG 40.0281
CYS 50.0066
GLN 60.0150
CYS 70.0210
ILE 80.0069
LYS 90.0119
THR 100.0038
TYR 110.0103
SER 120.0062
LYS 130.0368
PRO 140.0143
PHE 150.0099
HIS 160.0141
PRO 170.0096
LYS 180.0233
PHE 190.0146
ILE 200.0081
LYS 210.0120
GLU 220.0307
LEU 230.0300
ARG 240.0339
VAL 250.0221
ILE 260.0273
GLU 270.0782
SER 280.0235
GLY 290.0231
PRO 300.0333
HIS 310.0098
CYS 320.0160
ALA 330.0402
ASN 340.0230
THR 350.0214
GLU 360.0081
ILE 370.0156
ILE 380.0182
VAL 390.0092
LYS 400.0119
LEU 410.0206
SER 420.0267
ASP 430.0438
GLY 440.0325
ARG 450.0089
GLU 460.0196
LEU 470.0080
CYS 480.0095
LEU 490.0084
ASP 500.0095
PRO 510.0108
LYS 520.0129
GLU 530.0089
ASN 540.0140
TRP 550.0107
VAL 560.0068
GLN 570.0121
ARG 580.0110
VAL 590.0073
VAL 600.0058
GLU 610.0160
LYS 620.0080
PHE 630.0084
LEU 640.0148
LYS 650.0173
ARG 660.0157
ALA 670.0427
GLU 680.0095
ASN 690.0049

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.